Search

everythinglearnresearchcommunity

for

Search:↓

Many children with alopecia areata also have other autoimmune diseases.

Children with alopecia areata should only get thyroid screening if they have Down syndrome, a family history of thyroid disease, atopy, or signs of thyroid problems.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

No treatment showed significant long-term hair growth benefits for alopecia areata.

Salmon patches on the neck may relate to the severity and recurrence of alopecia areata.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Microneedling with triamcinolone helps hair regrowth in ophiasis alopecia areata.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Topical tacrolimus is effective and safe for treating alopecia areata.

A man regrew hair in 15 days using Pracchana and cupping therapy.

Alopecia areata involves immune response and gene changes affecting hair loss.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Non-immune factors play a significant role in alopecia areata.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.